DOT-HARRT for HIV-Infected South African Adults

针对感染艾滋病毒的南非成年人的 DOT-HARRT

基本信息

  • 批准号:
    7774326
  • 负责人:
  • 金额:
    $ 12.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-15 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

The early years of the combination antiretroviral therapy (ART) era have brought about dramatic reductions in the morbidity and mortality associatedwith HIV infection in industrialized countries and recently, international and local initiative have allow access to HAART in the developing world. Preliminary data from my prior work and other have shown that good adherence is feasible in resource-limited settings, but it is unclear whether these results are reproducible in scaled ART programs and what interventions would likely be effective at maximizing adherence in such settings. Peer advocates have been used to improve adherence with medical therapies in a variety of settings. In order to investigate the potential utility of peer- advocates in South Africa, I propose to conduct a randomized trial in which 300 patients will be assigned to either peer-DOT-HAART or self-administration of a twice daily combination of Stavudine, Lamivudine and Efavirenz for 24 months. The specific aims of this study are: 1) to evaluate the impact of peer-DOT HAART on control of viral burden and immune restoration as measured by viral load and CD4 T cell counts; 2) to evaluate the impact of DOT-HAART on treatment adherence; 3) the determination the proportion of genotypic HAART resistance in the peer-DOT vs. self-administered HAART arms; 4) to compare the incidence of new or recurrent opportunistic infection in the peer-DOT vs. self-administered HAART. My hypothesis is that the patients in the peer-DOT-HAART arm will have high levels of treatment adherence and hence more effective in controlling viral burden, thereby limiting the likelihood of virologic failure, drug resistance, and disease progression. This study will generate critical data on an alternative community- based approach of delivering HAART which may become a standard of care throughout sub-Saharan Africa and the developing world. My career development plan is based on a post-graduate training program, which includes comprehensive coursework at the Johns Hopkins University and University of Cape Town, structured mentoring, and guidance from a thesis committee. My career plan and research proposal are consistent with my long-term goals of becoming an effective independent investigator, and optimizing treatment outcomes in HIV-infected in sub-Saharan Africa.
联合抗逆转录病毒疗法(ART)时代的早期, in the incidence发病率and mortality死亡associated关联with HIV HIV感染in industrialized工业化countries国家and recently最近, 国际和地方倡议使发展中国家能够获得高效抗逆转录病毒疗法。的初步数据 我以前的工作和其他人的工作表明,在资源有限的情况下,良好的坚持是可行的,但它是 目前尚不清楚这些结果是否可在规模化的ART项目中重现,以及可能的干预措施 在这种情况下,有效地最大限度地提高依从性。同伴倡导者被用来改善 在各种环境中坚持医学治疗。为了研究peer的潜在效用, 在南非的倡导者,我建议进行一项随机试验,其中300名患者将被分配到 无论是同行DOT-HAART或自我管理的司他夫定,拉米夫定和 依法韦仑24个月。本研究的具体目的是:1)评估同伴DOT HAART的影响 通过病毒载量和CD 4 T细胞计数测量的病毒负荷控制和免疫恢复; 2) 评价DOT-HAART对治疗依从性的影响; 3)确定 基因型HAART耐药在同行DOT与自我管理HAART武器; 4)比较, 新的或复发的机会性感染的发病率在同行DOT与自我管理的HAART。我 一个假设是,对等DOT-HAART组的患者将具有高水平的治疗依从性, 因此更有效地控制病毒负荷,从而限制病毒学失败的可能性,药物 抵抗力和疾病进展。这项研究将产生一个替代社区的关键数据- 提供HAART的一种基于基础的方法,可能成为整个撒哈拉以南非洲的护理标准 和发展中国家。我的职业发展计划是基于研究生培训计划, 包括约翰霍普金斯大学和开普敦大学的综合课程, 结构化的指导和论文委员会的指导。我的职业规划和研究计划是 这与我成为一名有效的独立调查员的长期目标一致, 撒哈拉以南非洲艾滋病毒感染者的治疗结果。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Progression and persistence of low-grade cervical squamous intraepithelial lesions in women living with human immunodeficiency virus.
感染人类免疫缺陷病毒的女性低度宫颈鳞状上皮内病变的进展和持续性。
  • DOI:
    10.1097/lgt.0b013e3182403d18
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Zeier,MicheleDesire;Botha,MatthysHendrik;vanderMerwe,FrederickHaynes;Eshun-Wilson,Ingrid;vanSchalkwyk,Marije;laGrange,Marina;Mason,Deidre;Louw,Mercia;Nachega,JeanB
  • 通讯作者:
    Nachega,JeanB
Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications.
  • DOI:
    10.1007/s11904-009-0017-9
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Nachega, Jean B;Trotta, Maria Paola;Ammassari, Adriana
  • 通讯作者:
    Ammassari, Adriana
Impact of timing of antiretroviral therapy initiation on survival of cervical squamous intraepithelial lesions: a cohort analysis from South Africa.
抗逆转录病毒治疗开始时间对宫颈鳞状上皮内病变生存的影响:来自南非的队列分析。
  • DOI:
    10.1258/ijsa.2012.012040
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    1.4
  • 作者:
    Zeier,MD;Nachega,JB;VanDerMerwe,FH;Eshun-Wilson,I;VanSchalkwyk,M;LaGrange,M;Mason,D;Louw,M;Botha,MH
  • 通讯作者:
    Botha,MH
Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectives.
HIV 大流行时代成人活动性结核病的管理、当前做法和未来前景。
  • DOI:
    10.2174/187152611795589726
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nachega,JeanB;Rosenkranz,Bernd;Simon,Gary;Chaisson,RichardE;Diacon,Andreas;Taljaard,Jantjie
  • 通讯作者:
    Taljaard,Jantjie
Targeting HIV: past, present and future.
针对艾滋病毒:过去、现在和未来。
  • DOI:
    10.2174/187152611795589690
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zeier,MichèleD;Nachega,JeanB
  • 通讯作者:
    Nachega,JeanB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEAN BISIMWA NACHEGA其他文献

JEAN BISIMWA NACHEGA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEAN BISIMWA NACHEGA', 18)}}的其他基金

University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
南非匹兹堡大学艾滋病毒合并症研究培训项目
  • 批准号:
    10401787
  • 财政年份:
    2019
  • 资助金额:
    $ 12.91万
  • 项目类别:
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
南非匹兹堡大学艾滋病毒合并症研究培训项目
  • 批准号:
    9923781
  • 财政年份:
    2019
  • 资助金额:
    $ 12.91万
  • 项目类别:
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
南非匹兹堡大学艾滋病毒合并症研究培训项目
  • 批准号:
    10597672
  • 财政年份:
    2019
  • 资助金额:
    $ 12.91万
  • 项目类别:
University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
南非匹兹堡大学艾滋病毒合并症研究培训项目
  • 批准号:
    9769223
  • 财政年份:
    2019
  • 资助金额:
    $ 12.91万
  • 项目类别:
Pittsburgh-Stellenbosch University AIDS-comorbidities Training Research Program (Pitt-SU AICoTRP)
匹兹堡-斯泰伦博斯大学艾滋病合并症培训研究计划 (Pitt-SU AICoTRP)
  • 批准号:
    9118550
  • 财政年份:
    2016
  • 资助金额:
    $ 12.91万
  • 项目类别:
DOT-HARRT for HIV-Infected South African Adults
针对感染艾滋病毒的南非成年人的 DOT-HARRT
  • 批准号:
    7564680
  • 财政年份:
    2006
  • 资助金额:
    $ 12.91万
  • 项目类别:
DOT-HARRT for HIV-Infected South African Adults
针对感染艾滋病毒的南非成年人的 DOT-HARRT
  • 批准号:
    7355990
  • 财政年份:
    2006
  • 资助金额:
    $ 12.91万
  • 项目类别:
DOT-HARRT for HIV-Infected South African Adults
针对感染艾滋病毒的南非成年人的 DOT-HARRT
  • 批准号:
    7065441
  • 财政年份:
    2006
  • 资助金额:
    $ 12.91万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了